Mb, Levis & Associates, LLC Organon & Co. Transaction History
Mb, Levis & Associates, LLC
- $215 Billion
- Q1 2025
A detailed history of Mb, Levis & Associates, LLC transactions in Organon & Co. stock. As of the latest transaction made, Mb, Levis & Associates, LLC holds 200 shares of OGN stock, worth $1,744. This represents 0.0% of its overall portfolio holdings.
Number of Shares
200
Previous 200
-0.0%
Holding current value
$1,744
Previous $2.98 Million
0.2%
% of portfolio
0.0%
Previous 0.0%
Shares
2 transactions
Others Institutions Holding OGN
# of Institutions
804Shares Held
191MCall Options Held
1.53MPut Options Held
1.07M-
Black Rock Inc. New York, NY32.6MShares$284 Million0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA30.4MShares$265 Million0.01% of portfolio
-
Massachusetts Financial Services CO Boston, MA10.7MShares$93.4 Million0.06% of portfolio
-
State Street Corp Boston, MA9.34MShares$81.4 Million0.01% of portfolio
-
Lsv Asset Management Chicago, IL7.53MShares$65.6 Million0.26% of portfolio
About Organon & Co.
- Ticker OGN
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 254,330,000
- Market Cap $2.22B
- Description
- Organon & Co., a health care company, develops and delivers health solutions through a portfolio of prescription therapies in the United States and internationally. Its women's health portfolio comprises contraception and fertility brands, such as Nexplanon/Implanon, a long-acting reversible contraceptive. The company's biosimilars portfolio...